Home / Companies / Vera Therapeutics / Trends
Vera Therapeutics H-1B trends
Quarterly LCA aggregate trend points for Vera Therapeutics. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.
| Period | LCA count | Role titles | SOC codes | Avg wage low | Avg prevailing | Certified | Certification rate |
|---|---|---|---|---|---|---|---|
| 2024 Q3 | 1 | 1 | 1 | $190,000 | $168,667 | 1 | 100.0% |
| 2024 Q4 | 1 | 1 | 1 | $166,858 | $166,858 | 1 | 100.0% |
| 2025 Q2 | 1 | 1 | 1 | $187,000 | $172,453 | 1 | 100.0% |
| 2025 Q4 | 2 | 2 | 2 | $210,500 | $200,637 | 2 | 100.0% |
| 2026 Q2 | 1 | 1 | 1 | $277,530 | $272,397 | 1 | 100.0% |
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=vera+therapeutics&metric=lca_countJSON